Cite
HARVARD Citation
Stamatellos, V. et al. (2021). Disease‐modifying agents for multiple sclerosis and the risk for reporting cancer: A disproportionality analysis using the US Food and Drug Administration Adverse Event Reporting System database. British journal of clinical pharmacology. 87 (12), pp. 4769-4779. [Online].